Aoshima Kenji, Tanimizu Naoki
Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-0071, Japan.
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.
Regen Ther. 2025 Apr 22;29:447-454. doi: 10.1016/j.reth.2025.04.008. eCollection 2025 Jun.
Aside from successfully generating induced pluripotent stem cells from somatic cells, "reprogramming of differentiated cells" is a major technique for obtaining any type of target cells in vitro and in vivo by introducing critical transcription factors and using chemical compound combinations. In addition to these technical aspects, the physiological relevance of reprogramming has been extensively investigated, as growing evidence suggests that cellular reprogramming resulting in dedifferentiation or lineage conversion of a specific type of cell is associated with tissue injury and regeneration. We focus on cellular reprogramming in acute and chronically injured livers and summarize the molecular mechanisms governing the lineage transition between two types of liver epithelial cells, hepatocytes, and cholangiocytes.
除了成功地从体细胞中诱导生成诱导多能干细胞外,“分化细胞的重编程”是一种通过引入关键转录因子并使用化合物组合在体外和体内获得任何类型靶细胞的主要技术。除了这些技术方面,重编程的生理相关性也得到了广泛研究,因为越来越多的证据表明,导致特定类型细胞去分化或谱系转换的细胞重编程与组织损伤和再生有关。我们重点关注急性和慢性损伤肝脏中的细胞重编程,并总结了两种肝上皮细胞,即肝细胞和胆管细胞之间谱系转换的分子机制。